Rheumatoid Arthritis-Associated Interstitial Lung Disease Clinical Trials

8 clinical trials for Rheumatoid Arthritis-Associated Interstitial Lung Disease across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis — RECRUITING
• Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies — RECRUITING
• A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease — RECRUITING · PHASE2
• Treatment Strategy for Patients With RA-ILD — NOT_YET_RECRUITING · PHASE4
• A multicentre randomized double-blind placebo-controlled 48-week superiority study to compare the efficacy and safety of rituximab versus placebo in rheumatoid arthritis-associated interstitial lung disease - the BELLRA trial. — TERMINATED · PHASE4
• Rheumatoid Arthritis-associated Interstitial Lung Disease Definition — OTHER
• Value of KL-6 in Rheumatoid Arthritis-Associated ILD — OTHER
• Investigation on Risk Factors of Rheumatoid Arthritis Related Interstitial Lung Disease — OTHER

Refine this search